Healthcare provider profile · identity verified

Tonya M Spinale, NP

Nurse Practitioner · BRAINTREE, MA · NPI 1457526006

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	378	112
Lisinopril	Lisinopril	230	64
Amlodipine Besylate	Amlodipine Besylate	223	69
Levothyroxine Sodium	Levothyroxine Sodium	211	58
Omeprazole	Omeprazole	155	50
Losartan Potassium	Losartan Potassium	144	40
Metoprolol Succinate	Metoprolol Succinate	142	37
Simvastatin	Simvastatin	137	37
Lorazepam	Lorazepam	110	25
Trazodone Hcl	Trazodone Hcl	105	25
Hydrochlorothiazide	Hydrochlorothiazide	102	37
Gabapentin	Gabapentin	81	20
Albuterol Sulfate Hfa	Albuterol Sulfate	79	32
Tramadol Hcl	Tramadol Hcl	78	13
Metformin Hcl	Metformin Hcl	76	23
Furosemide	Furosemide	73	17
Famotidine	Famotidine	72	18
Metformin Hcl Er	Metformin Hcl	69	26
Sertraline Hcl	Sertraline Hcl	68	25
Fluoxetine Hcl	Fluoxetine Hcl	62	15
Atenolol	Atenolol	59	18
Rosuvastatin Calcium	Rosuvastatin Calcium	58	22
Eliquis	Apixaban	56	14
Escitalopram Oxalate	Escitalopram Oxalate	50	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	14
Alendronate Sodium	Alendronate Sodium	45	13
Ozempic	Semaglutide	41	suppressed
Jardiance	Empagliflozin	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Spironolactone	Spironolactone	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	14
Baclofen	Baclofen	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	13
Allopurinol	Allopurinol	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Glimepiride	Glimepiride	21	suppressed
Glipizide	Glipizide	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Prednisone	Prednisone	17	14
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	12
Temazepam	Temazepam	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Famciclovir	Famciclovir	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error